Bio Digital Artificial Intelligence
Enhancing Clinical Efficiency with AI Sleep Analysis: Cutting Both Cost and Time Joint Clinical Studies with CROs: SOMNUM™ AI Sleep Scoring D...
November 25, 2025 | News
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics announced that it h...
November 21, 2025 | News
Qure.ai, global leader in digital healthcare, announced its collaboration with Microsoft. Qure.ai will onboard its end-to-end lung cancer d...
November 20, 2025 | News
Partnership strengthens Bio-Techne's leadership in AI-enabled protein innovation NovoBody™ Duo molecules offer multi-specific binding capabilities...
November 19, 2025 | News
Genesis MedTech Group and the National University Health System (NUHS) have formed a strategic partnership to advance artificial intelligence (AI...
November 19, 2025 | News
Lunit, a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and comprehensive laboratory serv...
November 18, 2025 | News
-BostonGene, developer of the leading AI foundation model for cancer and the immune system, and Kyoto University, a research institution known for its...
November 14, 2025 | News
The partnership brings together Medit's open, global digital platform and OraQ's advanced AI technologies to create new pathways for innovation and connect...
November 13, 2025 | News
SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pac...
November 12, 2025 | News
Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced a research collabor...
November 11, 2025 | News
Vaccines remain the cornerstone of infectious disease control, but traditional development pathways are slow and resource‐intensive. Modern chall...
November 10, 2025 | Analysis
Lumonus, a leader in AI powered radiation oncology workflow solutions, announced the close of its A$25 million Series B financing round. The roun...
November 10, 2025 | News
Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel anti...
November 10, 2025 | News
Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and accelerates antibody-...
November 10, 2025 | News
Most Read
Bio Jobs
News
Editor Picks